Adicet Bio Gets Fast Track Designation For ADI-001 In Refractory Systemic Lupus Erythematosus
Adicet Bio, Inc. (ACET), a clinical stage biotechnology company, Wednesday said it received Fast Track Designation from the U.S. Food ...
Lupus Foundation of America1d
New Study Finds Racial and Gender-Specific Approaches May Boost Black Participation in Lupus Clinical Trials
In a new study published in Lupus Science & Medicine, researchers assessed clinical trial perceptions among a predominantly Black cohort of participants with systemic lupus erythematosus (SLE).
Healio1d
Menopausal hormone therapy may increase risks for lupus, systemic sclerosis
The odds of developing systemic lupus erythematosus or systemic sclerosis appear to significantly increase with the use of ...
Lupus Foundation of America2d
Allogene Therapeutics’ ALLO-329 Received FDA IND Clearance for Autoimmune Disease Trial
The U.S. Food and Drug Administration (FDA has cleared the investigational new drug (IND) application for Allogene ...
Too Old to Operate2d
Longitudinal Study of Genetic Risk in Renal and Non-Renal Lupus
The following is a summary of “Distinct genetic risk loci between biopsy-proven renal and non-renal lupus: a 10-year ...
Science Daily3d
New study identifies key protein's role in psoriasis
In a new study, researchers have determined that a protein called NF-kB c-Rel can intensify the symptoms of psoriasis when activated by signals from the body's immune system. Understanding how 'c-Rel' ...
rheumatologyadvisor5d
Increased ASCVD Risk Associated With Cutaneous Lupus Erythematosus
Individuals with cutaneous lupus erythematosus have an increased ASCVD risk when compared with those without cutaneous lupus erythematosus.